Associations of site-specific CD4 + -T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus
Restricted accessResearch articleFirst published online January, 2021
Associations of site-specific CD4 + -T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus
To comprehensively assess associations of site-specific CD4+-T-cell hypomethylation of the CD40-Ligand gene (CD40L) with disease activity of women with systemic lupus erythematosus (SLE).
Methods
CpG-sites within the DNA of the promotor and two enhancer regions (n = 22) of CD40L were identified and numbered consecutively. The rate of methylated DNA in isolated CD4+-T-cells of women with SLE were quantified for each methylation site by MALDI-TOF. Disease activity was assessed by SLE Disease Activity Index (SLEDAI). Associations of site-specific methylation rates with the SLEDAI scores were assessed by linear regression modelling. P values were adjusted according to Bonferroni-Holm as indicated.
Results
60 female SLE patients participated in the study (age 45.7 ± 11.1 years, disease duration 17.0 ± 8.3 years). Significant associations to the SLEDAI were noted for CpG22 hypomethylation of the promotor (β = −40.1, p = 0.017, adjusted p = 0.027), trends were noted for CpG17 hypomethylation of the promotor (β = −30.5, p = 0.032, adjusted p = 0.6), and for CpG11 hypermethylation of the second enhancer (β = 15.0, p = 0.046, adjusted p = 0.8).
Conclusion
Site-specific hypomethylation of the CD40L promotor in CD4+-T-cells show associations with disease activity in female SLE patients.
Alarcón-RiquelmeME.New attempts to define and clarify lupus. Curr Rheumatol Rep2019;
21: 11.
2.
RenauerPCoitPJeffriesMA, et al.
DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci Med2015;
2: e000101.
3.
RichardsonB.Epigenetically altered T cells contribute to lupus flares. Cells2019;
8: 127.
4.
LanataCMChungSACriswellLA.DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneity. Lupus Sci Med2018;
5: e000285.
5.
StricklandFMHewagamaAWuA, et al.
Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus: Diet, DNA methylation, and lupus. Arthritis Rheum2013;
65: 1872–1881.
6.
StricklandFMLiYJohnsonK, et al.
CD4+ T cells epigenetically modified by oxidative stress cause lupus-like autoimmunity in mice. J Autoimmun2015;
62: 75–80.
7.
JavierreBMFernandezAFRichterJ, et al.
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res2010;
20: 170–179.
8.
HeX-JDingYXiangW, et al.
Roles of 1,25(OH)2D3 and vitamin D receptor in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus by regulating the activation of CD4+ T cells and the PKCδ/ERK signaling pathway. Cell Physiol Biochem2016;
40: 743–756.
9.
LiYLiuYStricklandFM, et al.
Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes. Exp Gerontol2010;
45: 312–322.
10.
HurtadoCAcevedo SáenzLYVásquez TrespalaciosEM, et al.
DNA methylation changes on immune cells in systemic lupus erythematosus. Autoimmunity2020;
53: 114–118.
11.
JeffriesMASawalhaAH.Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. Int J Clin Rheumatol2011;
6: 423–438.
12.
LuQ.Lupus: the immunological impact of altered DNA methylation. J Investig Dermatol Symp Proc2015;
17: 26–28.
13.
RichardsonBScheinbartLStrahlerJ, et al.
Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum1990;
33: 1665–1673.
14.
StricklandFMPatelDKhannaD, et al.
Characterisation of an epigenetically altered CD4+ CD28+ kir+ T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry. Lupus Sci Med2016;
3: e000147.
15.
HewagamaAGorelikGPatelD, et al.
Overexpression of X-Linked genes in T cells from women with lupus. J Autoimmun2013;
41: 60–71.
16.
LuQWuATesmerL, et al.
Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol2007;
179: 6352–6358.
17.
ZhouYYuanJPanY, et al.
T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol2009;
132: 362–370.
18.
LettesjöHBurdGPMageedRA.CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB × NZW)F 1 lupus-prone mice: phenotype and possible role in autoreactivity. J Immunol2000;
165: 4095–4104.
19.
van VlodropIJHNiessenHECDerksS, et al.
Analysis of promoter CpG island hypermethylation in cancer: location, location, location!Clin Cancer Res2011;
17: 4225–4231.
20.
BadyPSciuscioDDiserensA-C, et al.
MGMT methylation analysis of glioblastoma on the infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol (Berl)2012;
124: 547–560.
21.
ZakynthinosEPappaN.Inflammatory biomarkers in coronary artery disease. J Cardiol2009;
53: 317–333.
22.
KnightJSKaplanMJ.Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol2013;
25: 597–605.
23.
HochbergMC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997;
40: 1725–1725.
24.
RosenbaumABleckESchneiderM, et al.
Assessment of direct versus indirect magnetic bead-based T-cell isolation procedures followed by magnetic bead-based DNA isolation. Lupus Sci Med2016;
3: e000167.
25.
EhrichMNelsonMRStanssensP, et al.
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci Usa2005;
102: 15785–15790.
26.
DomckeSBardetAFAdrian GinnoP, et al.
Competition between DNA methylation and transcription factors determines binding of NRF1. Nature2015;
528: 575–579.
27.
LiaoJLiangGXieS, et al.
CD40L demethylation in CD4+ T cells from women with rheumatoid arthritis. Clin Immunol2012;
145: 13–18.
28.
LianXXiaoRHuX, et al.
DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum2012;
64: 2338–2345.
29.
RezaieyazdiZSahebariMHatefM, et al.
Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?Lupus2011;
20: 1494–1500.
30.
AringerM.Inflammatory markers in systemic lupus erythematosus. J Autoimmun2020;
110: 102374.
31.
AlberHFSuessenbacherAWeidingerF.The role of inflammation in the pathophysiology of acute coronary syndromes. Wien Klin Wochenschr2005;
117: 445–455.
32.
LiuYKaplanMJ.Cardiovascular disease in systemic lupus erythematosus: an update. Curr Opin Rheumatol2018;
30: 441–448.
33.
HongK-MKimH-KParkS-Y, et al.
CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ζ-chain expression in T cells. Rheumatology 2017; 56: 467--476.
